1.XELOX ± Bevacizumab compared to FOLFOX4 ± Bevacizumab in first line metastatic colorectal cancer in a non-reimbursed health care system: A cost analysis.
Tan Jerry Y. ; Yacat Andrew A ; Sacdalan Dennis L.
Acta Medica Philippina 2015;49(2):64-67
INTRODUCTION: XELOX is non-inferior to FOLFOX-4 as a first-line treatment for metastatic colorectal cancer. This study compares the costs associated with XEL0X+/-bevacizumab versus FOLFOX4+/-bevacizumab in a non-reimbursed, out of pocket Philippine health care system.
METHODS: This is a cost-minimization analysis using Philippine General Hospital as base case and a typical Filipino patient of 60 kg with BSA 1.66. The outcome data were derived from the N016966 trial. These included the drugs capecitabine, 5-fluorouracil, oxaliplatin, and bevacizumab (BEV); chemotherapy cycles and corresponding hospital admission for each regimen; resources associated with treatment of adverse events such hospital days, ambulatory consultations, concomitant
medication, and central venous line insertion/removal, with costs and charges based on the local setting.
RESULTS: Highest cost (direct and/or indirect) was for FOLFOX4+BEV, followed by XEL0X+BEV, FOLFOX4, and then XELOX. The use of XELOX resulted in a cost saving of PhP 158,642 per patient compared with FOLFOX4. The use of XEL0X+BEV resulted in a cost saving of PhP 186,144 per patient compared with FOLFOX4+BEV.
CONCLUSION: XEL0X+/-BEV is less costly than FOLFOX4-F/-BEV in an out-of-pocket Philippine tertiary hospital setting from the patient's perspective.
Xelox ; Folfox ; Colorectal Neoplasms ; Capecitabine ; Fluorouracil ; Oxaliplatin ; Bevacizumab
2.Neoadjuvant chemoradiotherapy and total mesorectal excision in the management of locally advanced rectal carcinoma -- The PGH CRPoCan study group experience 2008-2009.
Co Henri S. ; Sacdalan Marie Dione S. ; Lopez Marc J. ; Real Irisly O. ; Ang Mark C. ; Fragante Edilberto V. ; Roxas Manuel T. ; Sacdalan Dennis L. ; Dimacali Andrew D.
Acta Medica Philippina 2015;49(2):60-63
INTRODUCTION: The use of neoadjuvant chemoradiotherapy (CRT) and total mesorectal excision (TME) has shown promising results in the management of locally advanced rectal carcinoma, and is associated with improvement in local control, disease free survival (DFS) and overall survival (OS). However, these clinical endpoints cannot be properly assessed due to poor follow up among many patients. Other endpoints such as negative circumferential resection margins (CRM), pathologic complete response (pCR) and sphincter-preserving surgery (SPS) may serve as indirect means of assessing successful treatment. This study reports the experience of the Philippine General Hospital (PGH) Colorectal Polyp and Cancer (CRPoCan) Study Group in using neoadjuvant CRT and TME in the management of locally advanced rectal carcinoma, towards quality care.
METHODS: The Integrated Surgical Information System (ISIS) database of the Department of Surgery, PGH was queried for rectal cancer patients with pretreatment clinical stage II and III disease that underwent neo-adjuvant CRT followed by TME between January 2008 and December 2009. The final surgical pathology reports of the subjects were reviewed for treatment response. Response was categorized as: (1) positive or negative CRM; and (2) with or without pCR. The study assessed whether SPS was done.
RESULTS: Of 140 potential neoadjuvant CRT patients followed by TME, 82 patients completed the treatment. Thirty two of the patients who completed treatment (39%) were eligible since the other 50 patients (61%) had no post-operative histopathology results. Among those eligible, 10 patients (31%) had pCR. Only 1 patient had a positive CRM. Of the 14 patients whose tumor distance was ?5cm from the anal verge, only 1 patient underwent SPS. The small sample size was mainly attributed to low resources or treatment. Non-availability of post-operative histopathology results was due to poor record keeping.
CONCLUSION: The PGH CRPoCan Study Group's use of neoadjuvant CRT followed by TME for locally advanced rectal carcinoma has resulted in acceptable numbers of pCR and clear CRM but has not translated into an increased number of SPS. Despite the limitations of the study, the institutionalization of the multidisciplinary team in the PGH CRPoCan Study Group and the implementation of the ISIS database program are considered the first steps towards quality health care.
Human ; Male ; Female ; Neoadjuvant Chemoradiotherapy ; Total Mesorectal Excision ; Polyp ; Surgical Pathology ; Rectal Cancer
4.Immunohistochemical profile, pattern of recurrence, and time to progression of non-metastatic breast cancer patients of the Department of Health-Breast Cancer Medicines Access Program.
Laja Nelson A. ; Lui Arthur Gregory A. ; Gumapon Joar Kent P. ; Ngelangel Corazon A. ; Guerrero Anna Melissa S. ; Sacdalan Dennis L. ; Rosario Rachel Marie B. ; Marcaida Romeo V.
Acta Medica Philippina 2015;49(2):18-25
BACKGROUND: Breast cancer remains to be the leading cause of malignancy among women and survival rates vary worldwide. Molecular and immunohistochemical (NC) profiling of breast cancer has emerged to improve treatment, which led to 6 different breast cancer subtypes luminal-A, luminal-B, Her-2 enriched, basal-like, daudin low, and normal breast. Essentially, this guides clinicians as to the choice of treatment and prognostication of disease. This study evaluates the characteristics of the different IHC subtypes of breast cancer among Filipinos as to pattern of recurrence and time to progression (TIP) within their 1st 2 years of follow-up.
METHODS: This is a retrospective cohort study, approved by the University of the Philippines Manila Research Ethics Board (UPMREB). Study population included breast cancer patients enrolled in the DOH-BCMAP and managed at the medical oncology clinics of the Philippine General Hospital (PGH) and Jose R. Reyes Memorial Medical Center (JRRMMC) from 1 May 2011 to 31 December 2013. Patients' demographics, disease and treatment profile were gathered from the medical charts. Patients were grouped into 12 different IHC subtypes utilizing only IHC staining results of Her2neu, ER and PR. Disease progression/ relapse and time to progression (UP) were primary outcomes analyzed and compared between subtypes using SPSS.
RESULTS: There were 368 eligible patients; 50% were >50 years old, 48% postmenopausal, 34% stage IIA, and 94% had invasive ductal carcinoma. About 88% completed their chemotherapy regimen, mostly AC-T. At 1 to 2 years follow-up, 18% had disease progression, mostly distant metastasis, with HER2neu(-)/ER(-)/PR(-), HER2(+), and HER2neu(-)/ER(+)/PR(+) subtypes having the most number of disease progression. The HER2neu(-)/ER(-)/PR(-) subtype had the shortest median TTP (11 months 9sd). HER2(+) subtype had median TTP of 14±8 sd, while HER2neu(-)/ER(+)/PR(+) had median TTP at 11.6±7.41 sd. The median TTPs among the different IHC subtypes were statistically comparable.
CONCLUSION: Filipinas with non-metastatic breast cancer after surgery and mainly on adjuvant chemotherapy started to develop disease progression/ relapse within the first 2 years of follow-up; 82% had no relapse. At these early years of follow-up, the median TTPs among the different breast cancer IHC subtypes who went into relapse were comparable, although HER2neu(+) regardless of ER/PR subtype tended to have more disease progression, followed by HER2neu(-)/ ER(-)/ regardless of PR subtype, and then HER2neu(-)/ ER(+)/ regardless of PR subtype. IHC resultant HER2neu(+) regardless of ER/PR and HER2neu(-)/ER(-)/PR(-/+) subtypes can serve as early prognosticators of breast cancer relapse.
Human ; Male ; Female ; Aged 80 And Over ; Aged ; Middle Aged ; Adult ; Breast Neoplasms ; Neoplasms ; Survival Rate ; Carcinoma ; Drug Therapy ; Medical Oncology
5.Measurement of anxiety and depression among cancer patients seen in an outpatient clinic of a tertiary hospital using the validated Hospital Anxiety and Depression Scale – Pilipino Version (HADS-P)
Kenneth Samala ; Paolo Dela Rosa ; Dennis Sacdalan
Philippine Journal of Internal Medicine 2021;59(4):259-265
Background:
Anxiety and depression, two of the most common affective disorders in cancer patients can affect one’s
compliance to treatment leading to poorer outcomes. Therefore, means of determining the psychological wellness of cancer patients through screening tools for anxiety and depression are an integral part of their management.
Objectives:
1) To measure the prevalence of anxiety and depression among cancer patients seen in an outpatient clinic of a tertiary hospital using the HADS-P. 2) To assess the impact of the following variables on symptoms of anxiety and depression: demographic, socio-economic, biological and health/clinical parameters.
Methodology:
This is a cross-sectional analytic study involving 381 cancer patients seen in the outpatient clinic. Symptoms
of anxiety and depression were measured using the HADS-P with an 11+ cut-off to identify possible cases of anxiety and depression. Univariate analysis, using STATA Version 13, was performed to identify correlates of anxiety and depression.
Results:
The prevalence of anxiety, depression and mixed diagnosis (anxiety and depression) amongst this study
population were 9.45%,4.72% & 2.89%, respectively. The multivariate analysis described non-college graduates (OR=1.82, CI 0.80-4.14), poor performance status (ECOG 2-3) (OR=5.34, CI 2.44-11.71) and the newly diagnosed and with ongoing treatment patients (OR= 12.02, CI 2.67-54.04 and OR=4.04, CI 0.88-18.58, respectively) as possible correlates of anxiety. Patients with poor performance status and have moderate-severe pain were likely to experience depression (OR= 6.14, CI 2.14-17.62; OR= 2.78, CI 0.92-8.46, respectively).
Conclusions
There are several factors that can affect one’s predisposition to having affective disorders. Clearly, there is a
necessity to allocate resources for screening and treating affective disorders among cancer patients to improve their compliance, to achieve a more holistic approach in their management and ultimately, to improve their quality of life.
Anxiety
;
Depression
6.Pre- and post-operative parameters among patients undergoing pre-operative embolization of meningioma: A tertiary referral center experience
Dennis Raymond L. Sacdalan ; Orlando R. Ignacio ; Glenn Marc G. Ignacio
Acta Medica Philippina 2024;58(Early Access 2024):1-6
Background and Objective:
Meningiomas represent the most prevalent benign intracranial tumors, comprising 13- 26% of primary intracranial neoplasms. These tumors derive their blood supply from both extracranial and intracranial circulation. Over recent decades, pre-operative embolization (POE) has emerged as a potential adjunctive therapy to surgery, aiming to reduce tumor vascularity. Our study seeks to explore the potential correlation between the extent of devascularization following POE of meningiomas and intraoperative blood loss.
Methods:
This cross-sectional study involved nine meningioma patients at a tertiary hospital, involving chart review of patients across four years. These patients were referred for POE due to angiographic evidence of a hypervascular mass between January 2018 and January 2022. We collected demographic data, tumor characteristics (including location, size, and vascular supply), and intraoperative variables such as total operative time and blood loss. Statistical analyses aimed to uncover correlations between vascularization degree and various factors.
Results:
Our population consists predominantly of females (53.68%), with a mean age of 45.85 ± 13.65 years. Only one mortality was recorded (7.7%). Pre-operative embolization achieved devascularization in the majority (69.2%) of cases, with approximately two-thirds (66.7%) experiencing complete devascularization. Mean total operative time stood at 336.11 ± 301.88 minutes, with a mean post-operative blood loss of 985.56 ± 1013.72 milliliters. Additionally, for those with recorded recovery times, the mean recovery time was 14.32 ± 13.51 hours.
:
Mortality rates showed no association with sex, devascularization status, or number of feeding vessel zones. Furthermore, the extent of devascularization did not correlate with age, sex, number of feeding vessel zones, postoperative blood loss, total operative time, or recovery time (p >0.05).
Conclusion
In summary, this study represents a significant endeavor to elucidate factors influencing meningioma outcomes following pre-operative embolization. Despite limitations regarding patient numbers, our study offers valuable insights into operative parameters and embolization considerations for future analyses in our tertiary center.
Meningioma
;
Radiology, Interventional
7.Cross-sectional cranial CT imaging findings and patterns in clinically diagnosed COVID-19 cases in a tertiary referral center
Dennis Raymond L. Sacdalan ; Jolly Jason S. Catibog ; Cesar C. de Guzman Jr.
Acta Medica Philippina 2024;58(Early Access 2024):1-5
Background:
Coronavirus Disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, presents not only as a respiratory ailment but also poses risks of neurological complications whose underlying mechanisms remain unclear. These complications range from mild to severe and may involve direct invasion of the central nervous system (CNS), disruption of the blood-brain barrier, or systemic cytokine effects. Diagnostic challenges persist due to the suboptimal sensitivity of RT-PCR assays.
Objective:
The present study aimed to review the contrast and non-contrast enhanced cranial CT images of all diagnosed COVID-19 patients in a tertiary referral center with the clinical impression of non-traumatic and nonoperative CNS pathologies.
Methods:
We conducted a cross-sectional study analyzing CT images of COVID-19 patients with neurological symptoms. Among 51 included patients, plain CT scans were predominantly used, revealing no acute infarcts or hemorrhages in the majority, while frontal lobe involvement was notable in cases with pathology. Chronic infarcts or ischemic changes were observed in over half of the cases, primarily affecting the anterior circulation. Only one case of meningitis was documented.
Results:
In the final analysis, 51 patients met the inclusion criteria out of the initial 64 enrolled. The study population, predominantly male with a mean age of 58.02 ± 20.87 years, mainly comprised patients solely diagnosed with COVID-19. Plain CT scans were favored over contrast-enhanced scans (76.50%, n = 39). While most patients had no acute infarcts or hemorrhages, the frontal lobe was commonly affected among stroke patients (9.8%, n = 5). Additionally, a significant portion of patients without acute stroke findings exhibited chronic infarcts or ischemic changes (57.69%, n = 15).
Conclusions
This study sheds light on the radiological patterns of CNS involvement in COVID-19 patients, highlighting frequent frontal lobe involvement possibly attributed to hypercoagulability and endotheliitis. Further research with larger sample sizes and MRI utilization is recommended to enhance our understanding of CNS manifestations in COVID-19. This study contributes to understanding COVID-19 neurological sequelae, particularly in terms of radiological patterns, among patients presenting with neurological symptoms. The findings highlight the need for comprehensive evaluation and management of neurological complications in COVID-19 patients.
COVID-19
;
stroke
8.Knowledge, attitudes, and practices in colorectal cancer screening in the Philippines
Joseff Karl U. Fernandez ; Martin Augustine B. Borlongan ; Michael Anthony A. Baliton ; Dennis L. Sacdalan ; Florge Francis A. Sy ; Analigaya R. Agoncillo ; Carl Lawrence C. Arenos ; Vincent F. Tatoy ; Timothy Joseph S. Uy ; Isabela Andrea L. Reveldez ; Steven Johnson L. Lim
Acta Medica Philippina 2024;58(Early Access 2024):1-15
Background and Objective:
Colorectal cancer (CRC) has the third highest incidence in the Philippines. Currently,
there is a paucity in literature that is focused on the knowledge, attitudes, and perceptions of Filipinos regarding CRC screening. This is the first study in the Philippines that describes this.
Methods:
This is a cross-sectional study that validated a 52-item Filipino questionnaire on the knowledge on
colorectal cancer, willingness to undergo CRC screening, and perceived benefits and barriers to fecal occult blood test (FOBT) and colonoscopy. The study enrolled household heads more than 20 years of age residing in both urban and rural communities in the Philippines.
Results:
The UP-PGH CRC KAP (University of the Philippines – Philippine General Hospital Colorectal Cancer
Knowledge, Attitudes, and Practices) and Rawl Questionnaire’s validity and internal consistency were established in a pilot study of 30 respondents. A total of 288 respondents were then enrolled to the main study group with a median age of 54.0. Knowledge scores for prognosis and utility of CRC screening were modest (6.3/12 and 8.4/20, respectively). Perceived benefit scores to FOBT and colonoscopy were high (9.9/12 and 13.9/16, respectively).Median scores to barriers to FOBT and colonoscopy were intermediate (22.5/36 and 35.8/60, respectively). Notably, a vast majority (86.1%) were willing to participate in CRC screening programs initiated by the government, and 46.9% agreed to undergo screening tests even as out-of-pocket expense.
Conclusion
The UP-PGH CRC KAP Questionnaire as well as the Filipino translation of the Rawl Questionnaire
are reliable and valid tools in extensively assessing the knowledge of Filipinos on CRC and willingness to undergo screening, as well as the benefits of and barriers to FOBT and colonoscopy. Knowledge scores were modest suggesting that directed educational campaigns and awareness programs can aid in increasing awareness about CRC and its screening. Household income and highest educational attainment were significantly positively correlated with knowledge scores, and perceived benefits of and barriers to CRC screening. Scores were generally comparable between urban and rural communities.
Knowledge
;
Attitudes